A Novel Echocardiography-Guided Strategy for Percutateous Closure of Atrial Septal Defect Assisted by PannaWire

A phase 4 trial registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 666 participants.

Also called NCT07054541

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; single masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 666 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT07054541
Planned start
(anticipated) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
China (from the registry)
Registry status
  • Not yet recruiting (from the registry)

Technical summary

Registry record NCT07054541. Randomized; single masking; primary purpose treatment. Start 2026-03-14 (anticipated); primary completion 2027-10-31 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
A Novel Echocardiography-Guided Strategy for Percutateous Closure of Atrial Septal Defect Assisted by PannaWire
Acronym
PANNA-ASD
Condition
Atrial Septal Defect (ASD)
Intervention (Procedure)
Ultrasound-guided intervention with assistance of specialized instruments
Intervention (Procedure)
fluoroscopy-guided intervention
Lead sponsor
Chinese Academy of Medical Sciences, Fuwai Hospital (class: other)

Record details

Record id
cardio:ct-nct07054541
Content hash
101fe770fa2fa786ae4c1269e112caa1a7a26355193feb66c8c163361adc830a